BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Czaja AJ. Difficult treatment decisions in autoimmune hepatitis. World J Gastroenterol 2010; 16(8): 934-947 [PMID: 20180231 DOI: 10.3748/wjg.v16.i8.934]
URL: https://www.wjgnet.com/1007-9327/full/v16/i8/934.htm
Number Citing Articles
1
Keiichi Fujiwara, Shin Yasui, Osamu Yokosuka. Autoimmune acute liver failure: an emerging etiology for intractable acute liver failureHepatology International 2013; 7(2) doi: 10.1007/s12072-012-9402-3
2
Co-occurrence of Wilson disease and Auto-Immune Hepatitis in 14-year-old female: A case reportAl Mustansiriyah Journal of Pharmaceutical Sciences 2022; 21(2) doi: 10.32947/ajps.v21i2.803
3
Amanda J. Nicoll, Stuart K. Roberts, Ricky Lim, Joanne Mitchell, Martin Weltman, Jacob George, Alan Wigg, Katherine Stuart, Paul Gow, Gerry MacQuillan, Edmund Tse, Miriam Levy, Siddharth Sood, Amany Zekry, Wendy Cheng, Jonathan Mitchell, Richard Skoien, William Sievert, Simone I. Strasser, Geoffrey W. McCaughan. Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levelsAlimentary Pharmacology & Therapeutics 2019; 49(10) doi: 10.1111/apt.15248
4
Sabina Di Matteo, Chiara Di Meo, Guido Carpino, Nicole Zoratto, Vincenzo Cardinale, Lorenzo Nevi, Diletta Overi, Daniele Costantini, Claudio Pinto, Elita Montanari, Marco Marzioni, Luca Maroni, Antonio Benedetti, Marco Viola, Tommasina Coviello, Pietro Matricardi, Eugenio Gaudio, Domenico Alvaro. Therapeutic effects of dexamethasone-loaded hyaluronan nanogels in the experimental cholestasisDrug Delivery and Translational Research 2022; 12(8) doi: 10.1007/s13346-022-01132-7
5
Farhad Sahebjam, John M. Vierling. Autoimmune hepatitisFrontiers of Medicine 2015; 9(2) doi: 10.1007/s11684-015-0386-y
6
John M. Vierling. Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and ManagementClinical Gastroenterology and Hepatology 2015; 13(12) doi: 10.1016/j.cgh.2015.08.012
7
A. García-Sabina, R. Rabuñal Rey, R. Martínez-Pacheco. Revisión sobre el uso de medicamentos en condiciones no incluidas en su ficha técnicaFarmacia Hospitalaria 2011; 35(5) doi: 10.1016/j.farma.2010.06.011
8
Qixia Wang, Carlo Selmi, Xinmin Zhou, Dekai Qiu, Zenshan Li, Qi Miao, Xiaoyu Chen, Jianhong Wang, Edward L. Krawitt, M. Eric Gershwin, Ying Han, Xiong Ma. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitisJournal of Autoimmunity 2013; 41 doi: 10.1016/j.jaut.2012.10.004
9
Roger W Chapman, Richard J Aspinall, Palak Trivedi, Gavin Wright, Michael Heneghan. Challenges in the use of corticosteroids in the management of autoimmune hepatitisBritish Journal of Hospital Medicine 2019; 80(10) doi: 10.12968/hmed.2019.80.10.594
10
Raúl J. Andrade, Guruprasad P. Aithal, Einar S. Björnsson, Neil Kaplowitz, Gerd A. Kullak-Ublick, Dominique Larrey, Tom H. Karlsen. EASL Clinical Practice Guidelines: Drug-induced liver injuryJournal of Hepatology 2019; 70(6) doi: 10.1016/j.jhep.2019.02.014
11
Albert J. Czaja, Michael P. Manns. Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune HepatitisGastroenterology 2010; 139(1) doi: 10.1053/j.gastro.2010.04.053
12
John M. Vierling. Diagnosis and Treatment of Autoimmune HepatitisCurrent Gastroenterology Reports 2012; 14(1) doi: 10.1007/s11894-011-0236-2
13
Marlen Ivón Castellanos Fernández, Deyanira la Rosa Hernández, Diego Enrique Cabrera Eugenio, Wilson Palanca, Zaily Dorta Guridi, Licet González Fabián. Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in CubaCurrent Therapeutic Research 2017; 85 doi: 10.1016/j.curtheres.2017.04.002
14
M. Tejedor Bravo, R.M. Martín Mateos, J. Martínez González, A. Albillos Martínez. Avances en la etiopatogenia, diagnóstico y tratamiento de la hepatitis autoinmuneMedicine - Programa de Formación Médica Continuada Acreditado 2012; 11(9) doi: 10.1016/S0304-5412(12)70344-X
15
Christopher Chang, Atsushi Tanaka, Christopher Bowlus, M. Eric Gershwin. The use of biologics in the treatment of autoimmune liver diseaseExpert Opinion on Investigational Drugs 2020; 29(4) doi: 10.1080/13543784.2020.1733527
16
Albert J. Czaja. Autoimmune hepatitis in special patient populationsBest Practice & Research Clinical Gastroenterology 2011; 25(6) doi: 10.1016/j.bpg.2011.09.011
17
Annarosa Floreani, Rodrigo Liberal, Diego Vergani, Giorgina Mieli-Vergani. Autoimmune hepatitis: Contrasts and comparisons in children and adults – A comprehensive reviewJournal of Autoimmunity 2013; 46 doi: 10.1016/j.jaut.2013.08.004
18
Ayumu Kanbe, Hiroyasu Ito, Yukari Omori, Akira Hara, Mitsuru Seishima. The inhibition of NLRP3 signaling attenuates liver injury in an α-galactosylceramide-induced hepatitis modelBiochemical and Biophysical Research Communications 2017; 490(2) doi: 10.1016/j.bbrc.2017.06.049
19
Cumali Efe, Ersan Ozaslan, Tugrul Purnak. Outcome of pregnancy in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome: A report of two casesClinics and Research in Hepatology and Gastroenterology 2011; 35(10) doi: 10.1016/j.clinre.2011.06.003
20
Suna Yapali, Nevin Oruc, Sibel Ilgun, Funda Yilmaz, Kenan Aksu, Mustafa Yilmaz, Fulya Gunsar. Acute presentation of autoimmune hepatitis in a patient with myasthenia gravis, thymoma, Hashimoto thyroiditis and connective tissue disorderHepatology Research 2012; 42(8) doi: 10.1111/j.1872-034X.2012.00985.x
21
Jean-Michel Pawlotsky, John Mchutchison. Goldman's Cecil Medicine2012;  doi: 10.1016/B978-1-4377-1604-7.00151-2
22
Ishita Salooja, Shilpi Srivastava, Alpana Raizada, Smita Nath. The Diagnostic Dilemma of Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap SyndromeIndian Journal of Medical Specialities 2025; 16(3) doi: 10.4103/injms.injms_171_24
23
Arash Motamed, Thang Tran, Mohamed H. Eloustaz. Obstetric Anesthesia and Uncommon Disorders2024;  doi: 10.1017/9781009070256.019
24
Cumali Efe, Tugrul Purnak, Ersan Ozaslan. Autoimmune hepatitis in the postpartum periodClinics and Research in Hepatology and Gastroenterology 2012; 36(4) doi: 10.1016/j.clinre.2012.02.006
25
A. Braga, C. Vasconcelos, J. Braga. Autoimmune hepatitis and pregnancyBest Practice & Research Clinical Obstetrics & Gynaecology 2020; 68 doi: 10.1016/j.bpobgyn.2020.03.007
26
Keiichi Fujiwara, Shin Yasui, Yutaka Yonemitsu, Makoto Arai, Tatsuo Kanda, Yoshihiro Fukuda, Masayuki Nakano, Shigeto Oda, Osamu Yokosuka. Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failureJournal of Hepato-Biliary-Pancreatic Sciences 2016; 23(4) doi: 10.1002/jhbp.326
27
Dorotea Božić, Ante Tonkić, Katarina Vukojevic, Maja Radman. A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis—Can We Draw a Line?Clinics and Practice 2023; 13(6) doi: 10.3390/clinpract13060125
28
Albert J. Czaja. Advances in the Current Treatment of Autoimmune HepatitisDigestive Diseases and Sciences 2012; 57(8) doi: 10.1007/s10620-012-2151-2
29
Roger W Chapman, Richard J Aspinall, Palak Trivedi, Gavin Wright, Michael Heneghan. Challenges in the use of corticosteroids in the management of autoimmune hepatitisGastrointestinal Nursing 2019; 17(Sup10) doi: 10.12968/gasn.2019.17.Sup10.S30
30
Marilena Durazzo, Alberto Premoli, Elena Paschetta, Paola Belci, Maurizio Spandre, Simona Bo. Overlap Syndromes of Autoimmune Hepatitis: An Open QuestionDigestive Diseases and Sciences 2013; 58(2) doi: 10.1007/s10620-012-2378-y
31
Severity and Outcome of Acute-on-Chronic Liver Failure is Dependent on the Etiology of Acute Hepatic InsultsJournal of Clinical Gastroenterology 2017; 51(8) doi: 10.1097/MCG.0000000000000823
32
A. J. Czaja. Review article: the management of autoimmune hepatitis beyond consensus guidelinesAlimentary Pharmacology & Therapeutics 2013; 38(4) doi: 10.1111/apt.12381
33
Keiichi Fujiwara, Nobuaki Nakayama, Naoya Kato, Osamu Yokosuka, Hirohito Tsubouchi, Hajime Takikawa, Satoshi Mochida. Infectious complications and timing for liver transplantation in autoimmune acute liver failure in Japan: a subanalysis based on nationwide surveys between 2010 and 2015Journal of Gastroenterology 2020; 55(9) doi: 10.1007/s00535-020-01699-3
34
Alessandro Granito, Simona Pascolini, Chiara Ricci, Marco Ferronato, Luigi Muratori, Francesco Vasuri, Tania Franceschini, Marco Lenzi, Paolo Muratori. Decompensated Cirrhosis as Presentation of LKM1/LC1 Positive Type 2 Autoimmune Hepatitis in Adulthood. A Rare Clinical Entity of Difficult ManagementGastroenterology Insights 2021; 12(1) doi: 10.3390/gastroent12010007
35
Soumyadeep Mukherjee, Arpita Kar, Najma Khatun, Puja Datta, Avik Biswas, Subhasis Barik. Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional SignaturesCells 2021; 10(8) doi: 10.3390/cells10081917
36
Nora V. Bergasa. Clinical Cases in Hepatology2022;  doi: 10.1007/978-1-4471-4715-2_4
37
Claude Eugene. Comment on the British Society of Gastroenterology guidelines for management of autoimmune hepatitis (part 2)Clinics and Research in Hepatology and Gastroenterology 2012; 36(6) doi: 10.1016/j.clinre.2012.06.009
38
Marta Casal Moura, Rodrigo Liberal, Hélder Cardoso, Ana Maria Horta e Vale, Guilherme Macedo. Management of autoimmune hepatitis: Focus on pharmacologic treatments beyond corticosteroidsWorld Journal of Hepatology 2014; 6(6): 410-418 doi: 10.4254/wjh.v6.i6.410
39
O. M. Drapkina, I. V. Maev, V. A. Akhmedov, L. G. Vologzhanina, A. I. Dolgushina, O. A. Igumnova, I. V. Kozlova, L. B. Lazebnik, S. V. Okovity, I. Yu. Pirogova, A. A. Saenko, L. V. Tarasova, T. A. Tikhonova, S. V. Turkina, I. B. Khlynov, O. V. Khlynova, Yu. V. Tsyganova. Clinical guidelines. Drug-induced liver injury (DILI) in adultsExperimental and Clinical Gastroenterology 2024; (12) doi: 10.31146/1682-8658-ecg-232-12-5-48
40
Alena Laschtowitz, Clara vom Endt, Martin Kluge, Julian Pohl, Josephine Frohme, Leke Wiering, Joscha Vonderlin, Lena Maria Greverath, Paul Horn, Tobias Püngel, Caroline Zöllner, Julia Benckert, Cornelius Engelmann, Florian Roßner, Münevver Demir, Frank Tacke, Moritz Peiseler. Second-line tacrolimus and mycophenolate mofetil in difficult-to-treat autoimmune hepatitisHepatology Communications 2026; 10(4) doi: 10.1097/HC9.0000000000000921
41
Peter Hunyady, Eva Herrmann, Joerg Bojunga, Mireen Friedrich-Rust, Anita Pathil, Stefan Zeuzem, Ulrike Mihm. Diagnostic value of a liver biopsy in patients with an acute liver failure or acute liver injuryEuropean Journal of Gastroenterology & Hepatology 2022; 34(7) doi: 10.1097/MEG.0000000000002382
42
Philippe J. Zamor. Diagnosis and Management of Autoimmune Hepatitis2020;  doi: 10.1007/978-3-030-33628-8_10
43
Tawhida Y. Abdel-Ghaffar, Mostafa M. Sira, Ahmad M. Sira, Tahany A. Salem, Ahmed A. El-Sharawy, Suzan El Naghi. Serological markers of autoimmunity in children with hepatitis AEuropean Journal of Gastroenterology & Hepatology 2015; 27(10) doi: 10.1097/MEG.0000000000000413
44
Jawad A. Ilyas, Christine A. O’Mahony, John M. Vierling. Liver transplantation in autoimmune liver diseasesBest Practice & Research Clinical Gastroenterology 2011; 25(6) doi: 10.1016/j.bpg.2011.09.008
45
T. J. Divers. Azathioprine ‐ a useful treatment for immune‐mediated disorders in the horse?Equine Veterinary Education 2010; 22(10) doi: 10.1111/j.0957-7734.2010.00117.x
46
A. García-Sabina, R. Rabuñal Rey, R. Martínez-Pacheco. Review of Use of Drugs for Conditions Not Included in Product CharacteristicsFarmacia Hospitalaria (English Edition) 2011; 35(5) doi: 10.1016/j.farmae.2010.06.006
47
Polymnia Galiatsatos, Sarit Assouline, Adrian Gologan, Nir Hilzenrat. Rituximab-induced autoimmune hepatitis: A case study and literature reviewCanadian Liver Journal 2020; 3(4) doi: 10.3138/canlivj-2020-0009
48
Kalaiyarasi Kaliyaperumal, Jane I. Grove, Robin M. Delahay, William J.H. Griffiths, Adam Duckworth, Guruprasad P. Aithal. Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applicationsJournal of Hepatology 2018; 69(4) doi: 10.1016/j.jhep.2018.05.013
49
Jiyoung Park, Hayeon Kim, In-Seung Lee, Kang-Hoon Kim, Yumi Kim, Yun-Cheol Na, Jang-Hoon Lee, Hyeung-Jin Jang. The therapeutic effects of Yongdamsagan-tang on autoimmune hepatitis modelsBiomedicine & Pharmacotherapy 2017; 94 doi: 10.1016/j.biopha.2017.07.015
50
Mona Abdel Latif Alsayed, Shymaa Mohsen Elbeah, Manal M. El-Desoky, Shereen Magdy Elziny, Ahmed Megahed. Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune HepatitisPediatric Gastroenterology, Hepatology & Nutrition 2020; 23(1) doi: 10.5223/pghn.2020.23.1.63
51
Raul S. Gonzalez, Kay Washington. Primary Biliary Cholangitis and Autoimmune HepatitisSurgical Pathology Clinics 2018; 11(2) doi: 10.1016/j.path.2018.02.010
52
Rui Ling Chen, Qi Xia Wang, Xiong Ma. Precision medicine for autoimmune hepatitisJournal of Digestive Diseases 2019; 20(7) doi: 10.1111/1751-2980.12786
53
Albert J Czaja. Animal models of autoimmune hepatitisExpert Review of Gastroenterology & Hepatology 2010; 4(4) doi: 10.1586/egh.10.42
54
Hind I. Fallatah, Hisham O. Akbar. Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical OverviewAutoimmune Diseases 2012; 2012 doi: 10.1155/2012/312817
55
Jimmy Daza, Lucas Soares Bezerra, Laura Santamaría, Roberto Rueda-Esteban, Heike Bantel, Marcos Girala, Matthias Ebert, Florian Van Bömmel, Andreas Geier, Andres Gomez Aldana, Kevin Yau, Mario Alvares-da-Silva, Markus Peck-Radosavljevic, Ezequiel Ridruejo, Arndt Weinmann, Andreas Teufel. Evaluation of four chatbots in autoimmune liver disease: A comparative analysisAnnals of Hepatology 2025; 30(1) doi: 10.1016/j.aohep.2024.101537